Hot Stocks: GoDaddy Inc. (NYSE:GDDY), Tesoro Corporation (NYSE:TSO), Exxon Mobil Corporation (NYSE:XOM), KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), Midcoast Energy Partners, L.P. (NYSE:MEP)

Web hosting firm GoDaddy Inc (NYSE:GDDY) on Wednesday reported second-quarter net loss of $29.8 million compared with a loss of $37.6 million last year. The net loss per Class A common share for the quarter was $0.46 versus a loss of $0.29 a year. GoDaddy Inc. (NYSE:GDDY) belongs to Technology sector. Its net profit margin is -9.40% and weekly performance is 7.91%. On last trading day company shares ended up $29.47. GoDaddy Inc. (NYSE:GDDY) distance from 50-day simple moving average (SMA50) is 4.47%.

Tesoro Corp. (NYSE:TSO) reported second quarter net earnings of $582 million or $4.59 per share, compared to $224 million or $1.70 per share for the year-ago quarter. Income from continuing operations for the latest quarter were $586 million or $4.62 per diluted share. Tesoro Corporation (NYSE:TSO) shares moved up 1.34% in last trading session and ended the day at $98.12. TSO Gross Margin is 14.90% and its return on assets is 6.00%. Tesoro Corporation (NYSE:TSO) quarterly performance is 11.00%.

Exxon Mobil Corporation (NYSE:XOM) will add flexibility to process light crudes at its Beaumont refinery, increasing production capacity by approximately 20,000 barrels per day. This expansion will further strengthen ExxonMobil’s integrated downstream portfolio in Southeast Texas. Exxon Mobil Corporation (NYSE:XOM) shares remains unchanged in last trading session and ended the day at $77.17. XOM Gross Margin is 25.10% and its return on assets is 8.10%. Exxon Mobil Corporation (NYSE:XOM) quarterly performance is -11.77%.

On July 29, KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug (IND) application for KB003, an anti-GM-CSF monoclonal antibody (mAb), in patients with chronic myelomonocytic leukemia (CMML), and that the IND is now active. On 05 August, KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) shares fell -2.87% and was closed at $2.03. KBIO EPS growth in last 5 year was 42.80%. KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) year to date (YTD) performance is -85.33%.

Midcoast Energy Partners, L.P. (NYSE:MEP) announced July 29, that the board of directors of its general partner has declared a quarterly cash distribution of $0.3525 per unit, or $1.41 per unit on an annualized basis, on all of its outstanding common and subordinated units for the quarter ended June 30, 2015. The approved distribution represents an increase of 1.4 percent over the previous quarter’s distribution and an 8.5 percent increase compared to the second quarter of 2014. The distribution is payable on August 14, 2015, to unitholders of record at the close of business on August 7, 2015. Midcoast Energy Partners, L.P. (NYSE:MEP) shares fell -7.94% in last trading session and ended the day at $11.02. MEP Gross Margin is 17.80% and its return on assets is -2.70%. Midcoast Energy Partners, L.P. (NYSE:MEP) quarterly performance is -14.71%.

Leave a Reply

Your email address will not be published. Required fields are marked *